Ryan Schneider, a director at Anthem (ANTM), recently picked up 1,300 shares. The buy increased his stake by 38 percent, and came to a total price of just under $500,000.
Schneider was the last insider to buy at the company as well, picking up shares back in February. Overall, company insiders, including both C-suite executives and directors, have been big sellers of shares in the past three years.
Overall, company insiders own just 0.2 percent of company shares.
In the past year, shares have performed about in-line with the S&P 500 index. The healthcare plan provider has seen revenues rise but earnings drop over the past year.
Healthcare plans haven’t been a big focus for investors in the broader healthcare space have been focused on Covid vaccines rather than on healthcare plans.
Action to take: The insider buying is rare here, but sellers at the company have missed out as the company continues to steadily move higher. Investors may like shares, as the company currently yields 1.2 percent right now, but has a history of raising its dividend over time.
For traders, the steady uptrend is likely to continue. The October $390 calls, last going for about $12.25, could offer mid-to-high double-digit returns in the weeks ahead.
Disclosure: The author of this article has no position in the company mentioned here, but may trade after the next 72 hours. The author receives no compensation from any of the companies mentioned in this article.